Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLCT
901
DELISTED
Collectors Universe
CLCT
| $21.3M | 0.02% |
744,719
-6,700
| -0.9% | -$180K |
|
|
RTEC
902
DELISTED
Rudolph Technologies Inc
RTEC
| $21.3M | 0.02% |
891,996
+73,160
| +9% | +$1.88M |
|
|
WBT
903
DELISTED
Welbilt, Inc.
WBT
| $21.3M | 0.02% |
906,200
+175,400
| +24% | +$3.87M |
|
|
CSII
904
DELISTED
Cardiovascular Systems, Inc.
CSII
| $21.3M | 0.02% |
899,300
+369,500
| +70% | +$9.31M |
|
|
IPXL
905
DELISTED
Impax Laboratories, Inc.
IPXL
| $21.3M | 0.02% |
1,279,300
+649,200
| +103% | +$11.9M |
|
906
Capri Holdings
CPRI
$1.77B
| $21.3M | 0.02% |
+338,000
| New | +$18.5M |
|
907
XPO
XPO
$24.5B
| $21.2M | 0.02% |
669,705
-155,846
| -19% | -$3.98M |
|
908
Flowers Foods
FLO
$1.52B
| $21.2M | 0.02% |
1,097,700
+144,100
| +15% | +$2.77M |
|
|
ALOG
909
DELISTED
Analogic Corp
ALOG
| $21.2M | 0.02% |
252,854
+61,006
| +32% | +$5.04M |
|
|
SVA
910
DELISTED
Sinovac Biotech, Ltd
SVA
| $21.2M | 0.02% |
2,687,400
+517,200
| +24% | +$3.87M |
|
911
International Paper
IP
$21.8B
| $21.1M | 0.02% |
+385,123
| New | +$20.7M |
|
|
NAVG
912
DELISTED
Navigators Group Inc
NAVG
| $21.1M | 0.02% |
433,800
+31,400
| +8% | +$1.68M |
|
|
ARRS
913
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $21.1M | 0.02% |
821,498
+526,898
| +179% | +$14.8M |
|
914
Bassett Furniture
BSET
$171M
| $21M | 0.02% |
559,800
+41,700
| +8% | +$1.6M |
|
915
Diamondrock Hospitality Co
DRH
$2.5B
| $21M | 0.02% |
1,860,684
+1,287,200
| +224% | +$14.3M |
|
|
CIT
916
DELISTED
CIT Group Inc.
CIT
| $21M | 0.02% |
+426,300
| New | +$20.7M |
|
917
Renasant Corp
RNST
$3.96B
| $21M | 0.02% |
513,239
-78,300
| -13% | -$3.27M |
|
918
Civeo
CVEO
$345M
| $20.9M | 0.02% |
637,375
+13,075
| +2% | +$360K |
|
919
Freeport-McMoran
FCX
$96.9B
| $20.9M | 0.02% |
+1,100,571
| New | +$16.6M |
|
920
Arthur J. Gallagher & Co
AJG
$65.5B
| $20.9M | 0.02% |
329,600
+11,200
| +4% | +$715K |
|
921
Culp Inc
CULP
$43.8M
| $20.8M | 0.02% |
620,200
-7,146
| -1% | -$225K |
|
|
BBL
922
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $20.8M | 0.02% |
515,300
-441,200
| -46% | -$16.4M |
|
923
AGNC Investment
AGNC
$12.9B
| $20.7M | 0.02% |
1,025,329
-1,552,880
| -60% | -$31.9M |
|
924
SS&C Technologies
SSNC
$18.8B
| $20.7M | 0.02% |
510,800
-165,000
| -24% | -$6.72M |
|
|
SRCL
925
DELISTED
Stericycle Inc
SRCL
| $20.7M | 0.02% |
303,820
-267,500
| -47% | -$18.2M |
|
Similar funds
Jim Simons's Q4 2017 Portfolio in Review
As of Q4 2017, Jim Simons held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Jim Simons's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Jim Simons added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Jim Simons's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Jim Simons fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Jim Simons's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Jim Simons opened 521 new positions and closed 386 in Q4 2017.
- Jim Simons's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.